TD Private Client Wealth’s Usana Health Sciences USNA Stock Holding History

TD Private Client Wealth’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.33K	Buy	+92	New	+$1.58K	﹤0.01%	1454

Other funds holding USNA

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Capital Advisors Ltd Shaker Heights, Ohio $987M AUM 13.52% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

TD Private Client Wealth's USNA Position: Q3 2026 in Review

TD Private Client Wealth opened a new position in Usana Health Sciences (USNA) in Q3 2026: 92 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #1454 among its holdings.

20 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

TD Private Client Wealth held 92 shares of Usana Health Sciences worth $1.33K as of Q3 2026.
Usana Health Sciences was a new TD Private Client Wealth position in Q3 2026.
Usana Health Sciences made up ﹤0.01% of TD Private Client Wealth's portfolio in Q3 2026, its #1454 holding.
20 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on TD Private Client Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.